Search Tag: Hologic

2017 19 Oct

Patients in Clinical Studies Report 100% Satisfaction Hologic, Inc. has announced that it has received an additional European Medical Device Directive (MDD) certification for SculpSure®, a state-of-the-art body contouring laser treatment. The device is now certified to treat a double chin (also known as the submental area), marking the product's...Read more

2017 06 Oct

  - New Panther Fusion Module Expands System's Molecular Testing Capabilities, Increases Efficiency and Flexibility for the Laboratory   Hologic, Inc. has announced that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its Panther Fusion® Flu A/B/RSV assay running on the new Panther Fusion®...Read more

2017 04 Oct

- Initial Proceeds from New $1.5 Billion Term Loan and $1.5 Billion Revolving Credit Line Used to Refinance Senior Secured Debt - - Funds Also Expected to Contribute to Retirement of Remaining Convertible Notes - Hologic, Inc.has announced  that the Company has entered into an amended and restated credit agreement consisting of a new, five-year $1.5...Read more

2017 04 Oct

- Proceeds Expected to Contribute to Retirement of Remaining Convertible Notes - Hologic, Inc. has announced that it has launched, subject to market and other conditions, a private offering of $350 million aggregate principal amount of senior notes due 2025.  Hologic intends to use the proceeds of the offering and available cash,...Read more

2017 03 Oct

  Hologic, Inc. has announced that the Company plans to release its financial results for the fourth quarter of fiscal 2017 on Wednesday, November 8, 2017 after the market closes.  In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time.   Interested participants may listen to the call by...Read more

2017 03 Oct

  Hologic, Inc. has announced that the Company plans to release its financial results for the fourth quarter of fiscal 2017 on Wednesday, November 8, 2017 after the market closes.  In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time.   Interested participants may listen to the call by...Read more

2017 30 Sep

Trailblazing Company Behind the Genius™ 3D Mammography™ Exam Celebrates Year of Innovations in Breast Health Hologic, Inc. has announced that Steve MacMillan, the Company's Chairman, President and Chief Executive Officer, will join selected employees to ring the Nasdaq Opening Bell on October 2 in conjunction with the start of Breast Cancer...Read more

2017 30 Sep

Patients in Clinical Studies Report 100% Satisfaction Rate   Hologic, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted an expanded FDA 510(k) clearance for Cynosure's non-invasive body contouring product,  SculpSure ®. The state-of-the-art body contouring laser treatment is now cleared to treat a double chin (also...Read more

2017 27 Sep

93% of Women Surveyed Reported Improved Comfort with the New System* Hologic, Inc . has announced the commercial availability of its new SmartCurve™ breast stabilization system, which has been clinically proven to deliver a more comfortable mammogram without compromising image quality, workflow or dose. 1  The SmartCurve system is available...Read more

2017 12 Sep

Fastest, Highest Resolution Breast Tomosynthesis System is Designed to Increase Clinical Confidence, Accuracy and Patient Comfort Hologic, Inc . has announced that the 3Dimensions ™  mammography system, the fastest, highest resolution breast tomosynthesis system ever, is available for purchase in Europe. [1]  The new product is the latest...Read more

2017 31 Aug

Transformational Workflow Solution Offers Real-Time Imaging of Tissue Samples, Resulting in Major Cost and Time Savings Hologic, Inc. has announced U.S. commercial availability of the Brevera® breast biopsy system with CorLumina®imaging technology, a groundbreaking real-time breast biopsy and verification system that enhances workflow, improves...Read more

2017 03 Aug

-- Company Posts Revenue of $806.1 Million, GAAP Diluted EPS of $0.21, and Non-GAAP Diluted EPS of $0.50 -- -- Organic Revenue Growth Led by Molecular Diagnostics and International Businesses -- Hologic, Inc. has announced the Company's financial results for the fiscal third quarter ended  July 1, 2017 .   GAAP diluted earnings per share (EPS)...Read more

2017 31 Jul

 Hologic, Inc. has announced that the Company will present at these upcoming investor conferences: The Canaccord Genuity Growth Conference in  Boston, MA  on  Wednesday, August 9  at  4 p.m. Eastern Time  (ET). Morgan Stanley's 15th Annual Global Healthcare Conference in  New York, NY  on  Monday, September 11  at  9:55 a.m. ET . Each prRead more

2017 12 Jul

Hologic, Inc. has announced that the Company plans to release its financial results for the third quarter of fiscal 2017 on Wednesday, August 2, 2017, after the market closes.  In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time. Interested participants may listen to the call by dialing 877-780-3379...Read more

2017 03 Jul

Hologic, Inc. has announced that it has notified holders of the 2.00% Convertible Exchange Senior Notes due 2042 (CUSIP No. 436440 AC5) issued March 5, 2012, and Wilmington Trust Company, the trustee, paying agent and conversion agent for the notes, that holders are eligible to convert the notes.   This conversion right is subject to the terms of...Read more

2017 29 Jun

New Panther Fusion® Module Expands Molecular Testing Capabilities, Increases Productivity and Flexibility for the Laboratory Hologic, Inc. has obtained a CE mark in Europe for its new Panther Fusion system and Panther Fusion assays for flu and respiratory testing, the Company has announced. The Fusion module system offers laboratories the ability...Read more

2017 21 Jun

Hologic, Inc. has announced  that it has obtained FDA clearance to market the Aptima® Herpes Simplex Virus (HSV) 1 & 2 molecular assay on the fully automated Panther® system. The test will be commercially available in the 50 United States, U.S. territories and Puerto Rico. According to the U.S. Centers for Disease Control and Prevention, infections...Read more

2017 16 Jun

SculpSure Now Cleared to Treat Five Areas of the Body Hologic, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted an expanded clearance for Cynosure's non-invasive body contouring product,  SculpSure , to treat the back and inner and outer thighs. The SculpSure treatment is already FDA-cleared for treatment of...Read more

2017 08 Jun

--Genius exam improves cancer detection and reduces recall rates for women of all ages and breast types, including the nearly 50 percent of women of breast cancer screening age who have dense breasts-- --Separate, recently published data analysis strongly supports starting breast cancer screening using tomosynthesis beginning at age 40-- Hologic,...Read more

2017 17 May

Hologic, Inc. (Nasdaq: HOLX) has announced that Charles J. Dockendorff has been elected to the Company's Board of Directors, effective immediately.  Mr. Dockendorff also was appointed to the Company's Audit and Finance Committee. Mr. Dockendorff, who has more than 25 years of experience in the global healthcare industry, was formerly the Executive...Read more

2017 04 Apr

Hologic, Inc. has announced that the Company plans to release its financial results for the second quarter of fiscal 2017 on Wednesday, May 10, 2017, after the market closes.  In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time. Interested participants may listen to the call by dialing 888-427-9376...Read more

2017 22 Mar

- Transaction Provides Entry into Large, Fast-Growing Medical Aesthetics Market, Boosts Hologic's Growth Rate - Hologic, Inc. has announced  that it has completed the acquisition of Cynosure, Inc., a leader in medical aesthetics systems and technologies, for $66 per share in cash. "We are pleased to complete our acquisition of Cynosure, and look...Read more

2017 18 Feb

HCV viral load test now available alongside HIV-1 assay and women's health menu on the fully automated Panther system Hologic, Inc. has announced that the United States Food and Drug Administration (FDA) has granted PMA approval for the Company's hepatitis C virus (HCV) assay for quantitation of HCV viral load and confirming active HCV infection...Read more

2017 14 Feb

-Expands Hologic's Scientific and Commercial Expertise into Large, Adjacent Medical Device Segment Growing at Double-Digit Rate  -Accelerates Hologic's Top- and Bottom-Line Growth Rates and is Immediately Accretive to Non-GAAP Earnings per Share  \ Hologic, Inc., a leader in women's health, and Cynosure, Inc. (Nasdaq: CYNO), a leader in medical...Read more

2017 13 Feb

Hologic, Inc. has announced that the Company will present at these upcoming investor conferences: The LEERINK Partners 6th Annual Global Healthcare Conference in New York, NY on Wednesday, February 15 at 3:30 pm Eastern Time (ET). The Raymond James 38th Annual Institutional Investor Conference in Orlando, FL on Monday, March 6 at&nbspRead more

2017 03 Feb

--Smaller 6 mm Diameter and Product Updates Are Designed to Enhance Patient Comfort and Improve Physician Ease-of-Use-- Hologic, Inc. has announced the launch of its next-generation NovaSure® ADVANCED global endometrial ablation (GEA) system in  the United States . The system has been FDA approved. The NovaSure system is designed to reduce...Read more

2017 02 Feb

- Strengthens Efforts to Build a Sustainable Growth Company - - Accelerates Top- and Bottom-Line Growth Rates, Increases Financial Flexibility - Hologic, Inc. has completed the divestiture of its blood screening business to long-time commercial partner, Grifols (MCE: GRF, MCE: GRF.P and NASDAQ: GRFS) for a purchase price of $1.85 billion in cash,...Read more

2017 09 Jan

Hologic, Inc. (Nasdaq: HOLX) has announced that Jan Verstreken has been named Regional President for  Europe ,  Middle East  and  Africa  (EMEA) and  Canada .  Mr. Verstreken's appointment completes Hologic's international sales leadership team, which includes  Sanjay Prabhakaran , Regional President for  Asia Pacific , and  Fernando Davico , General...Read more

2017 08 Jan

Hologic, Inc. has announced that the Company plans to release its financial results for the first quarter of fiscal 2017 on Wednesday, February 1, 2017, after the market closes.   In conjunction with the release, management will host a conference call that day at  4:30 p.m. Eastern Time . Interested participants may listen to the call by dialing...Read more

2017 03 Jan

--High-performing HIV viral load test now available alongside broad women's health menu on the fully automated Panther® system-- Hologic, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted PMA approval for the Company's HIV-1 viral load monitoring assay. The Aptima® HIV-1 Quant assay is a nucleic acid amplification...Read more